These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
269 related items for PubMed ID: 33177378
21. Prognostic value of neutrophil-to-lymphocyte ratio in cirrhosis patients undergoing transjugular intrahepatic portosystemic shunt. Zhang W, Aryan M, Chen Z, Khan W, Thompson B, Kwenda E, Geller B, Morelli G. Eur J Gastroenterol Hepatol; 2022 Apr 01; 34(4):435-442. PubMed ID: 34750323 [Abstract] [Full Text] [Related]
24. Identifying optimal candidates for early TIPS among patients with cirrhosis and acute variceal bleeding: a multicentre observational study. Lv Y, Zuo L, Zhu X, Zhao J, Xue H, Jiang Z, Zhuge Y, Zhang C, Sun J, Ding P, Ren W, Li Y, Zhang K, Zhang W, He C, Zhong J, Peng Q, Ma F, Luo J, Zhang M, Wang G, Sun M, Dong J, Bai W, Guo W, Wang Q, Yuan X, Wang Z, Yu T, Luo B, Li X, Yuan J, Han N, Zhu Y, Niu J, Li K, Yin Z, Nie Y, Fan D, Han G. Gut; 2019 Jul 01; 68(7):1297-1310. PubMed ID: 30415233 [Abstract] [Full Text] [Related]
25. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding. Su AP, Zhang ZD, Tian BL, Zhu JQ. Hepatobiliary Pancreat Dis Int; 2017 Apr 01; 16(2):169-175. PubMed ID: 28381381 [Abstract] [Full Text] [Related]
26. Second prophylaxis of variceal bleeding in cirrhotic patients with a high HVPG. Zhang M, Wang G, Zhao L, Wu Z, Zhang W, Zhang C. Scand J Gastroenterol; 2016 Dec 01; 51(12):1502-1506. PubMed ID: 27379704 [Abstract] [Full Text] [Related]
27. Transjugular Intrahepatic Portosystemic Shunt Creation and Variceal Coil or Plug Embolization Ineffectively Attain Gastric Variceal Decompression or Occlusion: Results of a 26-Patient Retrospective Study. Lakhoo J, Bui JT, Lokken RP, Ray CE, Gaba RC. J Vasc Interv Radiol; 2016 Jul 01; 27(7):1001-11. PubMed ID: 27106732 [Abstract] [Full Text] [Related]
28. Prognostic factors with the use of the transjugular intrahepatic portosystemic shunt for bleeding varices. Tyburski JG, Noorily MJ, Wilson RF. Arch Surg; 1997 Jun 01; 132(6):626-30; discussion 630-2. PubMed ID: 9197855 [Abstract] [Full Text] [Related]
29. Early transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a systematic review and meta-analysis. Zhou GP, Jiang YZ, Sun LY, Zhu ZJ. Eur Radiol; 2021 Jul 01; 31(7):5390-5399. PubMed ID: 33409783 [Abstract] [Full Text] [Related]
32. Endoscopic therapy + β-blocker vs. covered transjugular intrahepatic portosystemic shunt for prevention of variceal rebleeding in cirrhotic patients with hepatic venous pressure gradient ≥16 mmHg. Guo H, Zhang F, Yin X, Zhang M, Xiao J, Wang Y, Zhang B, Zhang W, Zou X, Zhuge Y. Eur J Gastroenterol Hepatol; 2021 Nov 01; 33(11):1427-1435. PubMed ID: 32868650 [Abstract] [Full Text] [Related]
33. Factors influencing in-hospital mortality for salvage percutaneous transjugular intrahepatic portosystemic shunting in cirrhotic patients with recalcitrant variceal bleeding after failed endoscopic intervention. Krige JEJ, Jonas EG, Setshedi M, Beningfield SJ, Lotze UK, Bernon MM, Burmeister S, Kloppers JC. S Afr Med J; 2023 Dec 31; 114(1):39-43. PubMed ID: 38525611 [Abstract] [Full Text] [Related]
34. MELD score for prediction of survival after emergent TIPS for acute variceal hemorrhage: derivation and validation in a 101-patient cohort. Casadaban LC, Parvinian A, Zivin SP, Lakhoo J, Minocha J, Knuttinen MG, Ray CE, Bui JT, Gaba RC. Ann Hepatol; 2015 Dec 31; 14(3):380-8. PubMed ID: 25864219 [Abstract] [Full Text] [Related]
36. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone versus TIPS combined with embolotherapy in advanced cirrhosis: a retrospective study. Xiao T, Chen L, Chen W, Xu B, Long Q, Li R, Li L, Peng Z, Fang D, Wang R. J Clin Gastroenterol; 2011 Aug 31; 45(7):643-50. PubMed ID: 21301360 [Abstract] [Full Text] [Related]
37. Prognostic impact of renal impairment and sodium imbalance in patients undergoing transjugular intrahepatic portosystemic shunting for the prevention of variceal rebleeding. Schepke M, Roth F, Koch L, Heller J, Rabe C, Brensing KA, Schiedermaier P, Schild HH, Sauerbruch T. Digestion; 2003 Aug 31; 67(3):146-53. PubMed ID: 12853726 [Abstract] [Full Text] [Related]
39. [Analysis of the long-term prognosis of transjugular intrahepatic portosystemic shunt treatment for esophagogastric variceal hemorrhage concomitant with sarcopenia in cirrhotic patients]. Wang XX, Zhang M, Yin XC, Gao B, Gu LL, Li W, Xiao JQ, Zhang S, Zhang W, Zhang X, Zou XP, Wang L, Zhuge YZ, Zhang F. Zhonghua Gan Zang Bing Za Zhi; 2024 Aug 20; 32(8):744-752. PubMed ID: 39267569 [Abstract] [Full Text] [Related]
40. Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis. Navadurong H, Thanapirom K, Wejnaruemarn S, Prasoppokakorn T, Chaiteerakij R, Komolmit P, Treeprasertsuk S. World J Gastroenterol; 2023 Aug 28; 29(32):4873-4882. PubMed ID: 37701131 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]